In recent years, the chemokine CCL2 (C-C motif ligand 2), also known as monocytic chemotactic protein 1 (MCP-1), and its receptor CCR2 (C-C motif receptor 2) have gained attention for their association with cancer occurrence and therapeutic resistance [10,11,12]. Here, CCL2 is linked to cancer.